Related Experiment Video

Updated: Oct 1, 2026

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal

Peter Hau1, Rainer Apfel, Petra Wiese

  • 1Department of Neurology, University of Regensburg, Germany. peter.hau@bkr-regensburg.de

Anticancer Research
|May 17, 2002
PubMed
Abstract

Insights

Melanoma-inhibiting activity (MIA/CD-RAP) is highly expressed in melanomas and glial tumors, suggesting a role in invasive and metastatic cancers. MIA/CD-RAP levels were elevated in cerebrospinal fluid of brain tumor patients, indicating diagnostic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor-specific antigens are crucial for cancer therapeutics and diagnostics.
  • Melanoma-inhibiting activity (MIA/CD-RAP) is implicated in tumor growth, invasion, and immunoreactivity.
  • Elevated MIA/CD-RAP levels are observed in advanced breast carcinomas and melanomas.

Purpose of the Study:

  • To investigate the expression extent and distribution of MIA/CD-RAP in various tumor types.
  • To assess MIA/CD-RAP levels in cerebrospinal fluid (CSF) and serum of patients with brain tumors.
  • To explore the functional role of MIA/CD-RAP in tumor cell behavior.

Main Methods:

  • Screening of melanoma, glioma, and other tumor cell lines, alongside non-malignant cells, for MIA/CD-RAP expression.
  • Utilized PCR, Western blot, and immunohistochemistry for expression analysis.
  • Measured MIA/CD-RAP protein levels in CSF and serum of patients with metastatic melanoma.

Main Results:

  • High MIA/CD-RAP mRNA and protein expression confirmed in all tested melanomas.
  • Significant MIA expression detected in glial tumors but not in non-glial CNS tumors.
  • Elevated MIA protein levels found in CSF of brain tumor patients compared to serum; MIA/CD-RAP expression showed specificity for melanocytic tumors but was also detected in some other carcinomas and normal cells.
  • Transformed glial tumor cells expressing MIA/CD-RAP exhibited reduced colony formation.

Conclusions:

  • MIA/CD-RAP appears to have a general function in invasive and metastatic tumors.
  • The protein's expression pattern suggests potential as a biomarker for certain cancers.
  • MIA/CD-RAP may play a role in regulating tumor cell proliferation and invasiveness.

More Related Videos

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...